A competitive, non-NMDA glutamate receptor antagonist (IC50s = 0.5 and 0.1 μM for AMPA and kainate receptors, respectively versus IC50 = 40 μM for NMDA receptors); used to target AMPA and kainate receptor responses and thus differentiate from that of NMDA receptors.